Suppr超能文献

40 年来治疗狂躁症的药物疗法比较疗效的累积贝叶斯网络荟萃分析。

A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.

机构信息

Physical Education Department, Chengdu Sport University, Chengdu, Sichuan, China.

Clinical Translational Science, Juntendo University Graduate School of Medicine, Bunkyo City, 2 Chome-1-1 Hongo, Tokyo, 113-8421, Japan.

出版信息

Psychopharmacology (Berl). 2022 Oct;239(10):3367-3375. doi: 10.1007/s00213-022-06230-5. Epub 2022 Sep 5.

Abstract

RATIONALE

Mania (or manic episodes) is a common symptom of bipolar disorder and is frequently accompanied by hyperactivity and delusions; given the cost and resources available, there is a paucity of evidence for direct comparison of different drugs.

OBJECTIVES

We aimed to provide evidence-based recommendations on the efficacy of overall currently used pharmacological treatments for patients with acute bipolar mania.

METHOD

We conducted a systematic review and network meta-analysis (NMA) using a Bayesian network frame. We searched the primary literature databases without language restrictions until Dec 18, 2021, for reports of randomized controlled trials (RCTs) of suspected antimanic drugs used as monotherapy for patients with acute bipolar mania, with the primary outcomes being efficacy (mean difference (MD), standardized mean difference (SMD) in the change of mania score).

RESULTS

Eighty-seven studies were included in which 18,724 manic participants (mean age = 34.6 years, with 50.36% males) were allocated at random to one of 25 active medication drug therapies or placebo, resulting in 87 direct comparisons on 192 data points. Tamoxifen (- 22·00 [- 26·00 to - 18·00]) had the best efficacy over the placebo. Meanwhile, risperidone (- 6·60 [- 8·40 to - 4·90]) was substantially more effective than placebo in treating acute mania. Carbamazepine, haloperidol, ziprasidone, cariprazine, olanzapine, quetiapine, aripiprazole, lithium, paliperidone, asenapine, and divalproex were noticeably more effective than placebo.

CONCLUSIONS

Overall, tamoxifen appears to be the most effective of the currently known pharmaceutical therapy available to treat acute mania or manic episodes; however, this conclusion is restricted by the scale of RCTs conducted, and risperidone was found to be the most effective medication among antipsychotics. Carbamazepine, haloperidol, ziprasidone, cariprazine, olanzapine, quetiapine, aripiprazole, lithium, paliperidone, asenapine, and divalproex were noticeably effective in treating acute mania or manic episodes.

摘要

背景

躁狂(或躁狂发作)是双相情感障碍的常见症状,常伴有活动过度和妄想;鉴于成本和可用资源,不同药物的直接比较证据很少。

目的

我们旨在为急性双相情感障碍躁狂患者的当前药理学治疗提供基于证据的建议。

方法

我们使用贝叶斯网络框架进行了系统评价和网络荟萃分析(NMA)。我们在没有语言限制的情况下,从最初的文献数据库中搜索了截至 2021 年 12 月 18 日的关于用于治疗急性双相情感障碍躁狂症患者的可疑抗躁狂药物单药治疗的随机对照试验(RCT)的报告,主要结局为疗效(躁狂评分变化的均值差(MD),标准化均数差(SMD))。

结果

纳入了 87 项研究,其中 18724 名躁狂参与者(平均年龄为 34.6 岁,男性占 50.36%)被随机分配到 25 种活性药物治疗药物或安慰剂之一,共产生 192 个数据点的 87 个直接比较。与安慰剂相比,他莫昔芬(-22.00 [-26.00 至-18.00])的疗效最佳。同时,利培酮(-6.60 [-8.40 至-4.90])在治疗急性躁狂方面明显优于安慰剂。卡马西平、氟哌啶醇、齐拉西酮、卡利拉嗪、奥氮平、喹硫平、阿立哌唑、锂、帕利哌酮、阿塞那平、丙戊酸钠在治疗急性躁狂方面明显优于安慰剂。

结论

总体而言,他莫昔芬似乎是目前已知治疗急性躁狂或躁狂发作的最有效药物疗法之一;然而,这一结论受到所进行的 RCT 规模的限制,利培酮被发现是抗精神病药物中最有效的药物。卡马西平、氟哌啶醇、齐拉西酮、卡利拉嗪、奥氮平、喹硫平、阿立哌唑、锂、帕利哌酮、阿塞那平、丙戊酸钠在治疗急性躁狂或躁狂发作方面明显有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验